FAP and familial pancreatic carcinoma: These studies suggest that β-therapy and α-therapy targeting FAP may offer effective treatment of pancreatic cancer, but it is currently in the clinical translational phase and further investigations using dPET are needed to determine the best mix of rapid FAP kinetics and physical radionuclide decay.